Explore
Validate
LearnNBP1-42312
antibody from Novus Biologicals
Targeting: CCL2
GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP1-42312 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NBP1-42312, RRID:AB_2070757
- Product name
- Rat Monoclonal CCL2/MCP1 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified.
- Reactivity
- Mouse
- Host
- Rat
- Isotype
- IgG
- Vial size
- 0.2 ml
- Concentration
- 0.1 mg/ml
- Storage
- Store at 4C. Do not freeze.
Submitted references LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
Myeloid cell-specific ABCA1 deletion protects mice from bacterial infection.
Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
Peña CG, Nakada Y, Saatcioglu HD, Aloisio GM, Cuevas I, Zhang S, Miller DS, Lea JS, Wong KK, DeBerardinis RJ, Amelio AL, Brekken RA, Castrillon DH
The Journal of clinical investigation 2015 Nov 2;125(11):4063-76
The Journal of clinical investigation 2015 Nov 2;125(11):4063-76
Myeloid cell-specific ABCA1 deletion protects mice from bacterial infection.
Zhu X, Westcott MM, Bi X, Liu M, Gowdy KM, Seo J, Cao Q, Gebre AK, Fessler MB, Hiltbold EM, Parks JS
Circulation research 2012 Nov 9;111(11):1398-409
Circulation research 2012 Nov 9;111(11):1398-409
Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
Kajii M, Suzuki C, Kashihara J, Kobayashi F, Kubo Y, Miyamoto H, Yuuki T, Yamamoto T, Nakae T
Clinical and experimental immunology 2011 Feb;163(2):235-41
Clinical and experimental immunology 2011 Feb;163(2):235-41
No comments: Submit comment
No validations: Submit validation data